[1] Theo SH,Matthias B,Erawan BK,et al.Pharmacological intervention in hepatic stellate cell activation and hepatic fibrosis. Front pharmacol,2016,7:33-35.
[2] Miguel V,Francisco S.Targeting the integrin interactome in human disease.Curr Opin Cell Biol,2018,55:17-23.
[3] Karsdal MA,Manon-Jensen T, Genovese F,et al.Novel insights into the function and dynamics of extracellular matrix in liver fibrosis.Am J Physiol Gastrointest Liver Physiol,2015,308(10):G807-830.
[4] Conroy KP,Kitto LJ,Henderson NC.αν integrins:key regulators of tissue fibrosis.Cell Tissue Res,2016,365:511-519.
[5] Hudson SV , Dolin CE, Poole LG,et al.Modeling the kinetics of integrin receptor binding to hepatic extracellular matrix proteins.Sci Rep,2017,7:12444.
[6] Desgrosellier JS, Cheresh DA. Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer,2010,10:9-22.
[7] Ashe HL.Modulation of BMP signalling by integrins.Biochem Soc Trans,2016,44:1465-1473.
[8] Kim NG, Gumbiner BM. Adhesion to fibronectin regulates Hippo signaling via the FAK-Src-PI3K pathway. J Cell Biol, 2015,210:503-515.
[9] Grimm FA, Iwata Y, Sirenko O, et al. High-content assay multiplexing for toxicity screening in induced pluripotent stem cell-derived cardiomyocytes and hepatocytes. Assay Drug Dev Technol, 2015,13:529-546.
[10] Pan L,Zhao Y,Yuan Z.Research advances on structure and biological functions of integrins.Springerplus,2016,5:1094.
[11] Targeting the integrin interactome in human disease.Vicente-Manzanares M,Francisco.Curr Opin Cell Biol,2018,55:17-23.
[12] Liu HC,Pan XF,Cao H.IL32γ promotes integrin αvβ6 expression through the activation of NF-κB in HSCs.Exp Ther Med,2017,14:3880-3886.
[13] Smith JR,Henderson NC.Recent progress on targeting the αvβ1 integrin for the treatment of tissue fibrosis. Expert Opin Drug Discov,2016,11:749-751.
[14] Sugiyama A, Kanno K,nishimichi N.Periostin promotes hepatic fibrosis in mice by modulating hepatic stellate cell activation via αv integrin interaction.J Gastroenterol,2016,51:1161-1174.
[15] Yan C,Yang QQ,Gong ZY.Activation of hepatic stellate cells during liver carcinogenesis requires fibrinogen/integrin αvβ5 in zebrafish.Neoplasia,2018,20:533-542.
[16] Karsdal MA,Nielsen SH,Leeming DJ,et al.The good and the bad collagens of fibrosis-their role in signaling and organ function. Adv Drug Deliv Rev,2017,121:43-56.
[17] Bansal R,Nakagawa S, Yazdani S,et al.Integrin alpha 11 in the regulation of the myo broblast phenotype: implications for fibrotic diseases.Exp Mol,2017,49:e396.
[18] Ponroy KP,Kitto LJ,Henderson NC.αν integrins: key regulators of tissue fibrosis.Cell Tissue Res,2016,365:511-519.
[19] Toru N,Hironori K,Hideki I.Ex vivo expansion of circulating CD34(+) cells enhances the regenerative effect on rat liver cirrhosis.Mol ther Methods Clin,2016,3:16025.
[20] Medina J,Caveda L,Sanz-Cameno P,et al.Hepatocyte growth factor activates endothelial proangiogenic mechanisms relevant in chronic hepatitis C-associated neoangiogenesis.J Hepatol,2003,38:660-667.
[21] Dubree NJ, Artis DR, Castanedo G, et al. Selective alpha4beta7 integrin antagonists and their potential as antiinflammatory agents. J Med Chem,2002,45:3451-3457.
[22] Joshi N,Kopec AK,Ray JL,et al, Fibrin deposition following bile duct injury limits fibrosis through an αMβ2-dependent mechanism.Blood,2016,127:2751-2762.
[23] Shi C, Velazquez P, Hohl TM, et al. Monocyte traf cking to hepatic sites of bacterial infection is chemokine independent and directed by focal intercellular adhesion molecule-1 expression. J Immunol,2010,184:6266-6274.
[24] Peng ZW,Rothweiler S,Wei G,et al.The ectonucleotidase ENTPD1/CD39 limits biliary injury and fibrosis in mouse models of sclerosing cholangitis.Hepatol Commun,2017,1:957-972.
[25] Tian F, Lu Y, Manibusan A, et al. A general approach to site-specific antibody drug conjugates. Proc Natl Acad Sci U S A ,2014,111:1766-1771. |
